Edap Tms (NASDAQ:EDAP) Downgraded by Wall Street Zen to Sell

Edap Tms (NASDAQ:EDAP) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Saturday.

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Edap Tms in a research report on Monday, December 29th. Two equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Reduce” and an average target price of $2.00.

Edap Tms Stock Down 1.1%

Edap Tms stock opened at $3.73 on Friday. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 0.97. Edap Tms has a 1-year low of $1.21 and a 1-year high of $5.05. The stock has a market cap of $139.46 million, a PE ratio of -4.84 and a beta of -0.19. The stock’s fifty day moving average is $4.21 and its two-hundred day moving average is $3.16.

Edap Tms (NASDAQ:EDAP) last posted its earnings results on Wednesday, March 25th. The medical equipment provider reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.16) by ($0.09). Edap Tms had a negative return on equity of 100.07% and a negative net margin of 41.24%.The business had revenue of $22.22 million for the quarter, compared to analysts’ expectations of $21.28 million. On average, sell-side analysts expect that Edap Tms will post -0.6 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Flax Pond Capital LLC acquired a new position in shares of Edap Tms during the 4th quarter worth $2,623,000. Leonteq Securities AG purchased a new position in shares of Edap Tms during the 4th quarter worth approximately $313,000. Rock Springs Capital Management LP raised its holdings in shares of Edap Tms by 1.3% in the fourth quarter. Rock Springs Capital Management LP now owns 1,286,500 shares of the medical equipment provider’s stock worth $4,233,000 after acquiring an additional 16,500 shares during the last quarter. Kovack Advisors Inc. acquired a new position in Edap Tms in the 4th quarter valued at about $53,000. Finally, Financial Planning Navigators CORP acquired a new position in shares of Edap Tms in the fourth quarter valued at approximately $33,000. Hedge funds and other institutional investors own 62.74% of the company’s stock.

Edap Tms Company Profile

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.